why choose us

First received: November 28, 2022

Clinical Trial: ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: HER2 Mutant Non-small Cell Lung Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1a/1b Study of ELVN-002 for the Treatment of Patients With HER2 Mutant Non-Small Cell Lung Cancer

Brief Summary: The goal of this clinical trial is to test ELVN-002 in people with cancers that have an abnormal HER2 gene.The main question the trial aims to answer is if ELVN-002 is safe and tolerable at different doses.A second main question is to evaluate the concentration of ELVN-002 in the blood at different doses and to see how this correlates with safety and see how the concentration of drug changes over time.The third main question is to see if ELVN-002 works to shrink cancers that have HER2 genetic abnormalities,…

Read more